PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Expenditure Sub-Program Areas track more specific PEPFAR expenditures.
Object classes provide highly specific ways that implementing partners are spending PEPFAR funds on programming.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
Beneficiary Expenditure data identify how PEPFAR programming is targeted at reaching different populations.
Sub-Beneficiary Expenditure data highlight more specific populations targeted for HIV prevention and treatment interventions.
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
Years of mechanism: 2010 2011 2012 2013 2014 2015
The Supply Chain Management Systems (SCMS) Project (USAID Contract #GPO-I-00-05-00032-00) is funded by the President's Emergency Plan for AIDS Relief (PEPFAR), SCMS brings together a partnership of 16 private sector, nongovernmental and faith-based organizations that are among the most trusted names in supply chain management and international public health and development. With offices in 17 countries and 350 dedicated staff members around the world, SCMS is helping to improve the lives of people living with HIV/AIDS in some of the countries most severely impacted by the pandemic. SCMS procures essential medicines and supplies at affordable prices; helps strengthen and build reliable, secure and sustainable supply chains systems; and fosters coordination of key stakeholders.
In Zimbabwe, the SCMS Project is implemented by JSI Research & Training Institute Inc, one of the 16 project partners. SCMS procures first line ARV drugs for approximately 59,000 adult patients. SCMS strengthens MOHCW, NatPharm and ZNFPC capacity in supply chain management through technical assistance and operations support which includes the design and implementation of distribution and LMIS systems; provision of staff to the MOHCW; provision of delivery and monitoring vehicles, fuel and maintenance; training in forecasting and quantification; an ARV stock audit system; support for warehousing improvements, and support for donor coordination. Additionally, the project strengthens MOHCW technical ART capacity by providing two key staff to the national ART program.
In FY 2011, SCMS will continue to second two medical officer positions to MOHCW AIDS & TB Programme: the National ART Coordinator and the Assistant National ART Coordinator. The project's support will include funding of site readiness assessments and site supervision aimed at enhancing the MOHCW's ART scale-up activities, the national quality of care initiative, and decentralization of ARV treatment. SCMS will continue to support supply chain systems which ensure that the ART treatment sites have an adequate supply of ARV drugs.
In FY 2011, SCMS will continue to procure up to approximately $200,000 of HIV rapid tests (Determine, SD Bioline, and the INsti tie breaker rapid tests to contribute to the achievement of the MOHCW targets (1,250,000 adults and children to be tested in CY 2012) and will assist the MOHCW in accurately quantifying HIV rapid test kit requirements. The national program' has moved to a serial HIV testing protocol during the first semester of 2010. Distribution for the rapid tests is part of SCMS's OHSS activities
In FY 2011, SCMS will continue to support operation maintenance and adjustment when necessary of the Logistics Management Information System (LMIS) currently ZISHAC (Zimbabwe Information System for HIVAIDS Commodities) - used by the LSU to captures patient data, consumption, stock on hand and losses and adjustment data, all used for informed quantification, storage and distribution decision-making.
In addition to ZISHAC, SCMS will continue to support the monthly stock audit of USG and other donor funded ARVs that was initiated in 2009 and controls receipt, storage and distribution of ARVs by the central level. SCMS will also continue to support the expanded stock audit that started in 2010 and covers ARVs managed at ART site level on a sample basis.
In FY 2011, SCMS will provide ongoing technical assistance and resource support to the Logistics sub-unit (LSU) which is now serving as the health commodities management unit for the whole MOHCW. The 20 current staff positions of the LSU are funded through SCMS, as is the SCM Advisor based at the MOHCW Directorate of Pharmacy Service.
The LSU manages the supply chain for the national MOHCW ART program. The LSU, along with the Directorate of Pharmacy Services (DPS), chairs the Procurement and Logistics Sub-committee of the ART Partners Forum, a central body for donor and partner collaboration and communication. SCMS, through the LSU, will continue to provide the following:
Product Selection: review national treatment guidelines, offer logistics considerations of choosing products, and work to minimize pack size proliferation
Quantification/Forecasting /Supply Planning: lead and manage quarterly updates of quantifications for Adult and Paediatrics ARV drugs for treatment, PMTCT and PEP, HIV test kits, TB and malaria drugs, Fluconazole and Male Circumcision commodities
Procurement: prepare procurement plans for all USG funded products; assist other partners in the development of procurement plans; highlight supply gaps and mobilize resources to fill these gaps
Warehousing: work with and support NatPharm (parastatal storage agent for all MOHCW HIV & AIDS commodities) to address any existing or potential storage challenges.
Distribution: support NatPharm with national bi-monthly distribution of ARV drugs and Male Circumcision Commodities (assuming funding for MC commodities procurement for 2012 will become available) providing 3 delivery trucks, fuel and maintenance, drivers, and per diem. SCMS will also continue to assist the MOHCW in implementing DTTU (Delivery Team Topping Up, an informed push distribution system for HIV and Syphilis rapid tests and PMTCT SdNVP and MER commodities.
Capacity Building: provide technical and operational support to MOHCW Directorate of Pharmacy Services and system-specific training on logistics for HIV/AIDS commodities Service Delivery Points as necessitated by addition of new sites and personnel attrition, as well as trainings to personnel in associated delivery systems like ZNFPC's DTTU.
This will cover the procurement of 71,720 male circumcision kits.
MTCT Prevention of Mother to Child Transmission
During 2010, MOHCW revised the PMTCT strategy to progressively increase the proportion of pregnant women who received more efficacious regimens (MER) based on WHO recommended option A (Mothers on AZT from 14 weeks and breastfeeding infants on daily Nevirapine during breastfeeding period). It is expected 20,176 mother/infants receive PMTCT MER in 2012. Part of the ARVs needed will be supplied by Global Fund Round 8 (6,058 mothers/infants); these PEPFAR funds will be used to procure drugs and other supplies to support MOHCW with the rollout of the new PMTCT guidelines. MOHCW will engage other partners to fill the remaining gap.
In FY 2011, SCMS will provide first-line ARVs for 80,000 adult patients, including 8,647 pregnant women in need of treatment for their own health, treated in public sector health facilities. SCMS supplied ARVs will contribute to meeting the MOHCW target (390,000 adult ART patients by the end of 2012 and ) which is also supported by the Government of Zimbabwe, Global Fund, the DFID-led Expanded Support Programme, the Clinton Foundation, and other donors such as Axios/Abbot.
To support these patients in accordance with the revised MOHCW Guidelines for ARV Therapy in Zimbabwe based on the WHO recommendation to switch patients away from Stavudine containing regimens, and based on the MOHCW strategy to put all new patients on Tenofovir-containing regimens and switch 20% of the existing patients from Stavudine to Tenofovir containing regimens in 2011 and 50% in 2012, SCMS will procure the following medicines: Lamivudine/Stavudine/Nevirapine 150/30/200mg for patients on the standard first line regimen, Lamivudine/Stavudine 150/30mg and Efavirenz 600mg for first line patients with tuberculosis; LamivudineZidovudine/Nevirapine 150/300/200mg and LamivudineZidovudine 150/300mg Efavirenz 600mg as alternative first line patients with tuberculosis. In addition, SCMS will also procure Tenofovir/Lamivudine 300/300mg combinations. These drugs will be FDA-approved/tentatively-approved generics, whenever possible and logical.
